Summary

Global Gold Nanorods Market was valued at USD 112.35 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 16.45% through 2029. Gold nanorods are tiny structures composed of gold atoms arranged in a rod-like form, typically measuring between 1 and 100 nanometers in diameter, with lengths often several times their diameter. These nanorods possess unique optical characteristics attributable to their size and shape, particularly in the visible and near-infrared regions of the electromagnetic spectrum. They are synthesized using precise chemical techniques to achieve elongated shapes with specific dimensions that influence their distinct properties. Notably, they exhibit strong surface plasmon resonance (SPR) within the visible to near-infrared range, making them valuable for applications in optics such as imaging, sensing, and therapeutic treatments. Surface modifications allow gold nanorods to be tailored for enhanced biocompatibility and targeted delivery in biomedical fields, ensuring stability in diverse biological environments. Their chemical stability and resistance to oxidation further enhance reliability in practical applications. Gold nanorods are extensively researched for biomedical uses such as cancer therapy, diagnostics, and imaging, owing to their ability to absorb and scatter light in the near-infrared range, ideal for techniques like photothermal therapy. In biosensing platforms, their high surface area-to-volume ratio and ease of functionalization with biomolecules enable sensitive detection of biomarkers and pathogens. In catalysis, their unique shape and surface properties contribute to heightened catalytic activity in reactions including oxidation and hydrogenation processes. Advances in nanofabrication techniques and surface chemistry continue to expand their potential applications.
While regulatory considerations regarding safety and environmental impact pose challenges, the market for gold nanorods remains niche but shows promising growth prospects across various industries. Continued research, technological advancements, and strategic partnerships will be pivotal in driving market expansion in the foreseeable future.
Key Market Drivers
Increasing R&D for biomedical applications
Increasing investments in research and development (R&D) aimed at biomedical applications are pivotal in driving the growth of the global market for gold nanorods. These investments are paving the way for innovative therapies, enhanced diagnostic tools, and novel biomedical solutions to address critical healthcare challenges. Gold nanorods possess unique properties, such as their ability to convert light into heat (utilized in photothermal therapy), which researchers are leveraging to develop advanced cancer treatment methods that selectively target cancer cells while minimizing damage to healthy tissue. Researchers at the Technical University of Munich (TUM) have developed a groundbreaking microrobot, named TACSI (Thermally Activated Cell-Signal Imaging), which they claim is the first of its kind. This newly designed micro-robotic system, featured in the journal Advanced Healthcare Materials, is circular and remarkably thin—about half the diameter of a human hair. Constructed from gold nanorods and fluorescent luminous dye enclosed in a biomaterial derived from algae, these microbots are currently utilized for in vitro applications. The developers envision potential innovative treatments, including targeted drug delivery to individual cells, facilitated by this microbot technology. Additionally, gold nanorods can be modified to effectively deliver drugs or therapeutic agents to specific sites within the body. In 2024, researchers published a study in the journal Nature presenting a synergistic method that combines chemo-photothermal treatment using gold nanorods (AuNRs) supported on thiol-functionalized mesoporous silica. This approach shows potential for significantly enhancing lung cancer therapy. By integrating gold nanorods, thiol-functionalized mesoporous silica, and drug release responsive to both pH and near-infrared (NIR) light, the research offers a comprehensive and effective treatment strategy to improve outcomes in lung cancer therapy. Future advancements built upon this approach hold promise for addressing cancer challenges and revolutionizing patient care. Researchers are actively exploring various surface modifications and targeting strategies to improve drug delivery efficiency and reduce potential side effects.
Gold nanorods exhibit strong optical properties, particularly in the near-infrared (NIR) range, making them valuable for imaging applications. They enhance contrast in imaging techniques like photoacoustic imaging and optical coherence tomography, improving tissue visualization and enabling early disease detection. Significant R&D efforts are dedicated to ensuring the biocompatibility and safety of gold nanorods for biomedical use. This includes studying their interactions with biological systems, assessing potential toxicity risks, and developing methods to enhance their stability and compatibility with living tissues.
In May 2024, ArgusEye, a company specializing in advanced sensor technology for biopharmaceutical manufacturing, announced the successful completion of a new funding round, raising approximately 2.8 million Euro. Voima Ventures led the round, with co-leadership from Eir Ventures, who continued their support from a previous Seed investment. This funding injection accelerates ArgusEye's efforts to revolutionize the development and production of new biomedicines. R&D initiatives are focused on navigating regulatory pathways to secure approval and commercialization of biomedical products based on gold nanorods. These comprehensive efforts underscore the critical role of ongoing R&D in advancing the application and market expansion of gold nanorods across various biomedical sectors.
Healthcare expenditure
Healthcare expenditure plays a crucial role in driving the global nanorods market by promoting innovation, advancing technology, and addressing healthcare challenges through nanotechnology applications in diagnostics, imaging, drug delivery, and therapeutics. Increased global healthcare spending stimulates demand for advanced medical technologies and treatments. Nanorods, particularly gold nanorods, are leading innovations in medical diagnostics, imaging, and therapy due to their distinctive properties.
According to a report by the Institute for Health Metrics and Evaluation, healthcare spending per person in the United States averaged $13,000 in 2021 and is projected to rise to $20,200 by 2050. This upward trend in healthcare expenditure underscores the increasing focus on managing chronic illnesses like cancer, cardiovascular diseases, and neurological disorders. Nanorods are being investigated for their potential in targeted drug delivery, enhancing imaging capabilities, and therapeutic applications, aligning with the need for effective chronic disease management.
Healthcare expenditure also promotes the development and adoption of precision medicine strategies, emphasizing personalized treatment approaches. Nanorods enable precise targeting of therapies and diagnostics at molecular and cellular levels, thereby supporting advancements in precision medicine initiatives.
The global aging population imposes greater demands on healthcare systems, leading to increased investments in healthcare services and technologies. Nanorods present promising solutions for age-related diseases and conditions, further propelling their adoption and market expansion.
Key Market Challenges
High Cost of Production
The high production costs pose a significant challenge for the global gold nanorods market. These costs stem from the intricate synthesis processes and the expensive raw materials necessary for their production. Consequently, gold nanorods may not be affordable for applications requiring large quantities or widespread use. Moreover, the competitiveness of gold nanorods is hindered by their high production costs compared to alternative materials or technologies offering similar functionalities at lower prices. This challenge restricts their market penetration across various industries.
Scaling production from laboratory to commercial levels involves substantial investments in equipment, facilities, and process optimization. The initial high investment required for scaling up can particularly deter smaller companies or startups from entering the market. Furthermore, the substantial resources needed for production can divert funds away from research and development efforts focused on exploring new applications or enhancing the performance of gold nanorods. As a result, innovation may be slowed, limiting the emergence of new market opportunities.
Technological Limitations
The synthesis of gold nanorods involves intricate processes that demand precise control over factors such as temperature, pH, and reaction times. Variations in these parameters can lead to inconsistencies in nanorod size, shape, and properties during production. Ensuring uniform size and shape distribution of gold nanorods is crucial for their performance in applications like biomedical diagnostics and therapeutic delivery. Technical challenges in maintaining this consistency can impact the reproducibility and reliability of nanorods. For example, deviations in seed-mediated growth methods may result in dimensional variations that affect their optical properties and effectiveness in targeted therapies.
Gold nanorods are susceptible to environmental influences such as pH shifts, temperature fluctuations, and light exposure, necessitating measures to ensure their stability across diverse conditions. This stability is vital for their practical application in various fields.
Functionalizing the surface of gold nanorods with molecules or biomolecules is essential for specific biomedical uses. However, challenges arise in achieving effective and stable functionalization while preserving the inherent properties of the nanorods. For instance, attaching targeting ligands to nanorod surfaces for precise cancer cell targeting requires robust chemical bonding techniques that do not compromise their optical or therapeutic qualities.
Integrating gold nanorods into practical devices or systems often involves addressing compatibility issues with existing technologies and materials. Technical considerations include ensuring the stability of nanorods within device components and optimizing their interaction with biological systems. For example, incorporating nanorods into biosensors requires overcoming compatibility challenges with sensor substrates and refining signal detection mechanisms.
Key Market Trends
Emerging applications in electronics
Gold nanorods demonstrate strong plasmonic properties, which are valuable in optical sensors and photodetectors. For example, researchers have devised highly sensitive optical sensors using gold nanorods to detect specific molecules or gases with precision and accuracy. These sensors capitalize on the nanorods' ability to interact with light at the nanoscale, enabling precise detection and analysis in fields such as environmental monitoring and biomedical diagnostics.
Gold nanorods are also being investigated for their potential in transparent conductive films utilized in touchscreens, displays, and solar cells. Their conductivity and optical transparency render them viable alternatives to conventional materials like indium tin oxide (ITO). By incorporating gold nanorods into these films, manufacturers can enhance conductivity while preserving high optical transparency, essential for applications requiring both functionalities. Researchers from China have developed a flexible infrared metamaterial absorber using gold nanorods dispersed in liquid crystal (LC), positioned on a gold film. They conducted a theoretical analysis of its total absorption capabilities, publishing their findings in the journal Scientific Reports in 2024. This metamaterial absorber exhibits key features such as flexibility, omnidirectional absorption, broadband capability, and tunability, indicating its potential applications in advanced smart metamaterial devices.
Gold nanorods are compatible with manufacturing processes for flexible and printed electronics, facilitating integration into wearable devices, smart textiles, and flexible displays. Their flexibility and robustness make them ideal for applications demanding conformal and bendable electronics. Manufacturers are actively exploring scalable techniques to print or deposit gold nanorods onto flexible substrates, expanding their utilization in consumer electronics and IoT devices.
In a recent publication in National Science Review, researchers detailed a study on dynamically and reversibly controlling surface plasmons through the transport of hot carriers. This research merges the rapid response of metal nanoplasmons with the optoelectronic modulation capabilities of semiconductors. By optically exciting hot electrons, the study manipulates the charge density within gold and adjusts the conductivity of nanogaps, enabling ultrafast and reversible switching of plasmon resonances. This advancement represents a significant prototype for optoelectronic switches in nanophotonic chips. There is a growing focus on research and development initiatives aimed at refining the synthesis, functionalization, and integration of gold nanorods into electronic devices. This encompasses exploring novel fabrication methods, enhancing material properties, and establishing scalable manufacturing processes suitable for widespread commercial applications.
Segmental Insights
Type Insights
Based on Type, the LSPR below 900nm emerged as the dominant segment in the global market for Gold Nanorods in 2023. Gold nanorods with LSPR below 900nm excel in biomedical applications, particularly in cancer treatment through photothermal therapy. Their optical properties include a strong absorption peak in the near-infrared (NIR) range (typically 700-900nm), aligning well with tissue transparency, which enhances their effectiveness. These nanorods also play essential roles in advanced imaging technologies such as photoacoustic imaging and optical coherence tomography. Their flexibility for functionalization with targeting molecules or drugs facilitates precise and targeted therapy delivery. Extensive research and development efforts continue to optimize these nanorods for biomedical use, advancing synthesis techniques, surface modifications, and understanding of their biological interactions. These ongoing innovations solidify their dominant position in the market, driven by their unique optical capabilities, therapeutic efficacy, versatility across medical applications, and continuous technological advancements.
End User Insights
Based on end user, the Healthcare & Pharmaceuticals segment emerged as the dominant in the global market for Gold Nanorods in 2023. The unique optical, thermal, and biocompatible characteristics of gold nanorods make them versatile tools for advancing diagnostics, therapies, and drug delivery systems in healthcare. Their potential to enhance treatment outcomes and patient care is a key driver of their prominent role in these crucial sectors. Gold nanorods can be customized with various molecules, such as drugs or targeting ligands, enabling precise and targeted delivery to specific cells or tissues. Their biocompatibility and ability to permeate cellular membranes position them as promising vehicles for therapeutic agents. This approach to targeted drug delivery reduces systemic toxicity and amplifies treatment effectiveness. Ongoing research and development efforts focus on refining the synthesis, functionalization, and biomedical applications of gold nanorods. This includes enhancing their stability, augmenting targeting capabilities, and exploring novel therapeutic applications. Continuous innovation in this field propels the expansion of their utility across healthcare and pharmaceutical industries.
Regional Insights
Based on Region, North America emerged as the dominant region in the Global Gold Nanorods Market in 2023. This can be attributed to advanced technology expertise, robust healthcare infrastructure, supportive regulatory frameworks, strong market demand, and extensive research and development efforts. North America serves as a center for technological innovation and research, particularly in biotechnology, healthcare, and nanotechnology. This environment facilitates significant progress in synthesizing, applying, and commercializing Gold Nanorods across various industries. The region benefits from advanced healthcare infrastructure and a robust pharmaceutical sector, where Gold Nanorods play a crucial role in biomedical applications such as drug delivery systems, diagnostics, and therapeutic treatments.
Key Market Players
• American Elements
• CD Bioparticles, Inc
• Cytodiagnostics Inc.
• Strem Chemicals, Inc.
• Merck KGaA
• Nanoshel LLC
• NanoComposix
• Sona Nanotech Inc.
• Nanowerk LLC
• Beijing DK Nano Technology Co. Ltd
Report Scope:
In this report, the Global Gold Nanorods Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Gold Nanorods Market, By Type:
o LSPR Below 900nm
o LSPR Above 900nm
• Gold Nanorods Market, By End User:
o Healthcare & Pharmaceuticals
o Electronics & Semiconductor
o Chemical and Material Science
o Others
• Gold Nanorods Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Gold Nanorods Market.
Available Customizations:
Global Gold Nanorods Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Impact of COVID-19 on Global Gold Nanorods Market
5. Impact of Wars on Global Gold Nanorods Market
6. Global Gold Nanorods Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type (LSPR Below 900nm, LSPR Above 900nm)
6.2.2. By End User (Healthcare & Pharmaceuticals, Electronics & Semiconductor, Chemical and Material Science, Others)
6.2.3. By Region
6.2.4. By Company (2023)
6.3. Market Map
7. Asia Pacific Gold Nanorods Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End User
7.2.3. By Country
7.3. Asia Pacific: Country Analysis
7.3.1. China Gold Nanorods Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End User
7.3.2. India Gold Nanorods Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End User
7.3.3. Australia Gold Nanorods Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End User
7.3.4. Japan Gold Nanorods Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value & Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End User
7.3.5. South Korea Gold Nanorods Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value & Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End User
8. Europe Gold Nanorods Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End User
8.2.3. By Country
8.3. Europe: Country Analysis
8.3.1. France Gold Nanorods Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End User
8.3.2. Germany Gold Nanorods Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End User
8.3.3. Spain Gold Nanorods Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End User
8.3.4. Italy Gold Nanorods Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End User
8.3.5. United Kingdom Gold Nanorods Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End User
9. North America Gold Nanorods Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End User
9.2.3. By Country
9.3. North America: Country Analysis
9.3.1. United States Gold Nanorods Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End User
9.3.2. Mexico Gold Nanorods Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End User
9.3.3. Canada Gold Nanorods Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End User
10. South America Gold Nanorods Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gold Nanorods Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By End User
10.3.2. Argentina Gold Nanorods Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By End User
10.3.3. Colombia Gold Nanorods Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By End User
11. Middle East and Africa Gold Nanorods Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By End User
11.2.3. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Gold Nanorods Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By End User
11.3.2. Saudi Arabia Gold Nanorods Market Outlook
11.3.2.1.1. By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By End User
11.3.3. UAE Gold Nanorods Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions
14. Global Gold Nanorods Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Product
16. Pricing Analysis
17. Competitive Landscape
17.1. American Elements
17.1.1. Business Overview
17.1.2. Company Snapshot
17.1.3. Products & Services
17.1.4. Financials (As Reported)
17.1.5. Recent Developments
17.2. CD Bioparticles, Inc.
17.3. Cytodiagnostics Inc.
17.4. Strem Chemicals, Inc.
17.5. Merck KGaA
17.6. Nanoshel LLC
17.7. NanoComposix
17.8. Sona Nanotech Inc.
17.9. Nanowerk LLC
17.10. Beijing DK Nano Technology Co. Ltd.
18. Strategic Recommendations
19. About Us & Disclaimer